We're sorry, in order to view this member's profile you must be a member. Please login, or apply for membership. If you're currently a member with us, but this is your first time logging in a while, your password may have changed for security reasons. In order to access the registry, please reset your password, or contact us today.
Claudia Klein is the CEO of YENO Awareness BV. She has over 15 years of experience as a causal diagnostician focusing on toxicology, cell dysfunction and holistic medicine. Her expertise is in biological regeneration medicine. She has been a speaker and lecturer in casual diagnostics and new approaches in medicine. Over the past 15 years, Claudia has been researching the cell mechanisms of information-based epigenetics and the possibility of transmitting targeted information to cells and their biochemical functional processes. Her work includes the physiological, biochemical and above all cell-communicative regeneration pathways of the body. Claudia says that YENO focuses on research and development of groundbreaking applied epigenetics and personalized medicine topics as well as the development of smart diagnostic software. YENO is years ahead compared to the worldwide research and has developed its own Personalized Medicine Brand, the GENOS Regulative. Nowadays, it counts with its own pharmacy production line in the German market. The company’s work is subject to careful quality management and a continuous quality development process, which form the basis for optimal and professional activity. YENO stands for a new, easy to use and modern medicine that combines the old knowledge from holistic and complementary medicine with state-of-the-art research. The focus of Claudia’s work is on the relationship to nature, humankind and the environment. She is looking forward to networking and connecting with other like-minded professionals, and to gaining the recognition and credibility of being a member.